Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice

mBio(2025)10.1128/mbio.01108-25Source: DataRank Database

Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice is a research paper published in mBio (2025). On theSindex it has a DataRank of 0.335. It has been cited 7 times, with 5 citing works in its 1-hop citation network.

N/A

0.335DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access7 citations · 5 citing works in its network

Download PDF

Cite:

Data availability

Repositories this paper deposited data in (declared in PubMed).

SRAPRJNA1168499

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 5.30)OA: goldTopics (74)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 93%Citation Network 7%

Base Score Contribution

0.312

From this paper's citation signal

Citation Network Contribution

0.0232

From 2 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 5 citers.

Advances in capsule-based fecal microbiota transplantation: clinical applications and innovations
Journal of Translational Medicine202511 citations147 referencesContributes 0.017
Successful fecal microbiota transplants in post-antibiotic treated recurrent Clostridioides difficile patients induce acylcarnitine and sphingolipid lipidomic shifts
Gut Microbes Reports20261 citations67 referencesContributes 0.010
Recent advances in the positive role of Clostridium in autoimmune diseases: as a crucial regulator of restoring immune-metabolic equilibrium
Frontiers in Immunology20260 citations231 referencesContributes 0.000
The Impact of Fecal Microbiota Transplantation on Host Immunity and Epithelial Restoration Following Clostridioides difficile Infection
Anaerobe20260 citations135 referencesContributes 0.000
Ecological and dietary strategies to constrain Clostridioides difficile
Cell Host & Microbe20260 citations184 referencesContributes 0.000

Authors (4)

Kimberly C. Vendrov ORCID,Vincent B. Young ORCID,Anna M. Seekatz ORCID,Sophie Millard

Live enrichment

PubMed:40454811 PMC:PMC12239565 OpenAlex:https://openalex.org/W4410959233

National Institutes of Health

Grant: P20GM146584, P20GM139769

National Institutes of Health

Grant: K01-DK111794

National Institutes of Health

Grant: AI124255, AI090871

NIGMS NIH HHS

Grant: R35 GM150609

NIGMS NIH HHS

Grant: P20 GM146584

NIGMS NIH HHS

Grant: P20 GM139769

NIDDK NIH HHS

Grant: K01 DK111794

NIAID NIH HHS

Grant: U01 AI124255

NIAID NIH HHS

Grant: U19 AI090871

National Institutes of Health

Grant: 3P20GM146584-02S1

Acquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University

National Institutes of Health

Grant: 1U19AI090871-01

Epidemiology and Genomics of Clostridium difficile

National Institutes of Health

Grant: 3P20GM139769-04S1

COBRE in Human Genetics

National Institutes of Health

Grant: 1U01AI124255-01

Systems biology of Clostridium difficile infection

National Institutes of Health

Grant: 7K01DK111794-02

Critical functions of the gut microbiota that mediate recovery from recurrent Clostridium difficile infection

FWCI

5.30

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.01108-25

publisherhttps://doi.org/10.1128/mbio.01108-25

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.01108-25

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40454811

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12239565

Fields of Study

Clostridium difficile and Clostridium perfringens researchGut microbiota and healthPharmacological Effects of Natural Compounds0301 basic medicine03 medical and health sciencesAnimalsClostridium InfectionsFecal Microbiota TransplantationMiceClostridioides difficileGastrointestinal MicrobiomeHumansRNA, Ribosomal, 16SFecesDisease Models, AnimalMice, Inbred C57BLFemaleMaleMetagenomicsMetabolomics

MeSH Terms

Gastrointestinal MicrobiomeFecal Microbiota TransplantationAnimalsClostridium InfectionsDisease Models, AnimalFecesFemaleHumansMaleMice, Inbred C57BLRNA, Ribosomal, 16SClostridioides difficileMiceMetabolomicsMetagenomics

Keywords

ClostridioidesMicrobiomeColonisation resistanceFecal bacteriotherapyMetagenomicsBiologyClostridium difficileHuman microbiomeMetabolomicsGut floraHost (biology)MicrobiologyTransplantationAntibioticsImmunologyMedicineBioinformaticsEcologyGeneGeneticsInternal medicineRecurrenceGut MicrobiomeFecal Microbiota TransplantClostridioides DifficileMaleFecal Microbiota TransplantationQR1-502Gastrointestinal MicrobiomeMice, Inbred C57BLMiceFecesDisease Models, AnimalRNA, Ribosomal, 16SClostridium InfectionsAnimalsHumansFemaleResearch Article

Sustainable Development Goals

SDG 0: Life in Land